Oncology News

Patients with hepatocellular carcinoma seen at a high-volume hospital had improved overall survival vs. patients seen at a low-volume hospital, according to published findings.

In a case-control study performed among Alaska Natives, hepatitis B surface antigen seroclearance was not associated with a decreased risk for developing hepatocellular carcinoma.

The real-world cost of care to treat hepatocellular carcinoma for patients with hepatitis C cirrhosis is very high, according to findings from a retrospective cohort study.

Bayer announced results of its phase 3 RESORCE clinical trial, indicating Stivarga improved overall survival in patients with unresectable hepatocellular carcinoma.

An estimated 746,000 deaths occur annually from liver cancer worldwide.

BARCELONA — New data presented at the International Liver Congress showed patients with chronic hepatitis B virus infection who receive long-term treatment with nucleos(t)ide analogues did not have an increased risk for all cancers. However, a slight increase in the development of colorectal and cervical cancers was observed, suggesting routine screening for these types of cancers among these patients is necessary.

Aspirin use was associated with a 2.7-fold to 3.6-fold decreased risk for developing intrahepatic, perihilar and distal cholangiocarcinoma, according to findings published in Hepatology.

Researchers recently developed the ITA.LI.CA prognostic system, which accurately predicted survival of Italian and Taiwanese patients with hepatocellular carcinoma, using data from the Italian Liver Cancer database. Further, the system may also serve as a potential use for designating treatment.

In a new study published in the Journal of Clinical Oncology, hepatocellular carcinoma incidence rates in Hispanics and blacks are expected to increase in the U.S. through 2030.

BARCELONA —  Nexavar plus a chemotherapy regimen was not superior to Nexavar alone in improving overall survival in a cohort of patients with hepatocellular carcinoma, according to findings presented at the International Liver Congress.